retatrutide clinical trial sign up Let's talk about a new weight loss medication: retrarutide. is a triple hormone receptor agonist that suppresses appetite; it also boosts metabolism and increases fat burning, making it one of the Phase III retatrutide study demonstrates

How Foods Can Influence GLP-1 Release Naturally Research shows that the types of foods you choose may help stimulate GLP-1 secretion in the gut

Healthy fats may support GLP-1 response, though evidence is mixed and context-dependent

No DEXA or detailed body composition data published

Therefore, no dosage adjustment is usually recommended when gliptins are combined with other pharmacological agents

The latest polls report that of the one in eight Americans who have taken a GLP-1 medication, about 38% have only taken them to help lose weight

A 2023 study of more than 17,000 patients published in the New England Journal of Medicine found that semaglutide reduced the risk of major cardiovascular events including heart attack, stroke and cardiovascular death by about 20% in overweight or obese adults who already have cardiovascular disease but not diabetes